Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Zager

Showing results (11-20 of 321) with videos related to

Pageof 33
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|March 21, 2018
Pharmacokinetic drug evaluation of talimogene laherparepvec for the treatment of advanced melanomaErin E Burke, Jonathan S Zager
JAMA Surgery|April 7, 2017
Metastasectomy for Abdominal Visceral Oligometastatic MelanomaDanielle K DePeralta, Jonathan S Zager
Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2008
Melanoma: promising new discoveries and treatment modalities for difficult clinical scenariosJonathan S Zager, Adil I Daud
Expert Opinion on Drug Metabolism & Toxicology|January 19, 2010
Isolated limb infusion for melanoma: a less morbid alternative to hyperthermic isolated limb perfusion in the USAlfredo A Santillan, Jonathan S Zager
Surgical Oncology Clinics of North America|March 15, 2015
Sentinel lymph node mapping in melanoma in the twenty-first centuryMatthew P Doepker, Jonathan S Zager
Clinical & Experimental Metastasis|February 12, 2022
Editorial: Novel Frontiers in Cancer MetastasisStanley P Leong, Jonathan S Zager
Clinical & Experimental Metastasis|February 12, 2022
Future perspectives: Novel Frontiers in Cancer MetastasisStanley P Leong, Jonathan S Zager
Annals of Surgical Oncology|July 10, 2019
ASO Author Reflections: Robotic Pelvic Lymph Node Dissection for Metastatic Melanoma-A Minimally Invasive Approach to a Difficult ProblemJohn T Miura, Jonathan S Zager
Future Oncology (London, England)|September 21, 2019
Neo-DREAM study investigating Daromun for the treatment of clinical stage IIIB/C melanomaJohn T Miura, Jonathan S Zager
Expert Opinion on Biological Therapy|November 6, 2018
Engineered oncolytic viruses to treat melanoma: where are we now and what comes next?Luke D Rothermel, Jonathan S Zager
Pageof 33

Showing results (11-20 of 321) with videos related to

Sort By:
Pageof 33
Expert Opinion on Drug Metabolism & Toxicology|March 21, 2018
Pharmacokinetic drug evaluation of talimogene laherparepvec for the treatment of advanced melanomaErin E Burke, Jonathan S Zager
JAMA Surgery|April 7, 2017
Metastasectomy for Abdominal Visceral Oligometastatic MelanomaDanielle K DePeralta, Jonathan S Zager
Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2008
Melanoma: promising new discoveries and treatment modalities for difficult clinical scenariosJonathan S Zager, Adil I Daud
Expert Opinion on Drug Metabolism & Toxicology|January 19, 2010
Isolated limb infusion for melanoma: a less morbid alternative to hyperthermic isolated limb perfusion in the USAlfredo A Santillan, Jonathan S Zager
Surgical Oncology Clinics of North America|March 15, 2015
Sentinel lymph node mapping in melanoma in the twenty-first centuryMatthew P Doepker, Jonathan S Zager
Clinical & Experimental Metastasis|February 12, 2022
Editorial: Novel Frontiers in Cancer MetastasisStanley P Leong, Jonathan S Zager
Clinical & Experimental Metastasis|February 12, 2022
Future perspectives: Novel Frontiers in Cancer MetastasisStanley P Leong, Jonathan S Zager
Annals of Surgical Oncology|July 10, 2019
ASO Author Reflections: Robotic Pelvic Lymph Node Dissection for Metastatic Melanoma-A Minimally Invasive Approach to a Difficult ProblemJohn T Miura, Jonathan S Zager
Future Oncology (London, England)|September 21, 2019
Neo-DREAM study investigating Daromun for the treatment of clinical stage IIIB/C melanomaJohn T Miura, Jonathan S Zager
Expert Opinion on Biological Therapy|November 6, 2018
Engineered oncolytic viruses to treat melanoma: where are we now and what comes next?Luke D Rothermel, Jonathan S Zager
Pageof 33